CRISPR therapy for rare blood disease delivers “life-changing” results
Targeting a pair of rare genetic blood diseases, the experimental therapy has so far been 100 percent effective in all 22 patients treated.
Targeting a pair of rare genetic blood diseases, the experimental therapy has so far been 100 percent effective in all 22 patients treated.
The new study, led by Dr. Sagar Sengupta from the National Institute of Immunology has however found a novel way to identify the disease as early as stage 1 through his lab’s work on microRNAs
A pledge by China to supply 2 billion doses of COVID-19 vaccines to other countries this year expands the commitments made by a nation that is already the largest exporter of the shots by far.
Maine has enacted a groundbreaking law that will ban the use of toxic PFAS compounds in all products by 2030, except in instances deemed “currently unavoidable”.
The move will allow pharmacists to automatically substitute the cheaper version, just as they do with generic pills for other kinds of drugs. It could save diabetics and health plans millions of dollars annually.
In 2015, the World Health Organization declared that glyphosate is “probably carcinogenic to humans.” Bayer now faces tens of thousands of legal claims from U.S. customers.
The report, appearing in The Journal of the National Cancer Institute, reflects good news for 11 of the 19 most common cancers among men, and for 14 of the 20 most common cancers among women.
More than one percent of Iceland’s working population participated in the pilot scheme, which cut the usual 40-hour working week to 35-36 hours with no reduction in overall pay, reports The Independent.
China has become the 40th country to be declared malaria-free. It has not had an indigenous case for four years.
The retailer claims its insulin options will save customers between 58% to 75% compared to branded products.